Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/15/2003CN1124156C Chinese-medicinal pills for treating rheumatism and preparing process thereof
10/15/2003CN1124155C Medicine for treating leukoderma and preparing process
10/15/2003CN1124150C Headache treating capsule
10/15/2003CN1124146C 'Pingweisu' capsule for treating gastric disease
10/15/2003CN1124141C Xinnaofukang capsule-for treating angiocardiopathy and cerebrovascular disease and its preparing process
10/15/2003CN1124140C Chinese medicine Tangzhi'an for treating peripheral nerve lesion of diabetes
10/15/2003CN1124131C Oil-soluble vitamin powder and making process thereof
10/15/2003CN1124130C Pharmaceutical preparation comprising colodronate as active ingredient and silicified microcrystalline cellulose as excipient
10/15/2003CN1124129C Solid foamed active substance preparations
10/14/2003US6633792 Method for controlling a coating process
10/14/2003US6632906 Good cohesion and low dermal irritation; comprises ketone groups cross-linked by a polyamine cross- linking agent
10/14/2003US6632845 Method for improving muscle control and muscle tone and improving sensory integration
10/14/2003US6632842 Reducing medication error and enhancing therapeutic compliance of an individual suffering from COPD by providing a single use inhaler
10/14/2003US6632841 Not in the form of cyclodextrin inclusion complex; in solution with lactic acid as solubilizer
10/14/2003US6632803 Pharmaceutical formulations containing voriconazole
10/14/2003US6632799 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
10/14/2003US6632796 Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof
10/14/2003US6632671 Nanoparticle encapsulation system and method
10/14/2003US6632634 Decay accelerating factor (DAF) and nucleic acid encoding it
10/14/2003US6632458 Food using γ-aminobutyric acid-enriched cruciferous plant
10/14/2003US6632457 Hydrophobic phase controlling a rate of release of the therapeutic agent from the hydrogel matrix; fatty acids and triglycerides
10/14/2003US6632456 Compositions for inhalation
10/14/2003US6632455 Molecular dispersion composition with enhanced bioavailability
10/14/2003US6632454 Multilayer pharmaceutical product for release in the colon
10/14/2003US6632453 Ciprofoxacin-metronidazole antibiotic composition
10/14/2003US6632452 Medicinal compositions retarded in the discoloration of phenolic hydroxyl compounds
10/14/2003US6632451 Therapy of disease by the release of drugs in the gastrointestinal tract in a location-and time-dependent manner
10/14/2003US6632446 Biocompatible substrates; free radical polymerization initiator; crosslinked networks of water soluble polymers; acrylated polyethylene glycol; microencapsulation
10/14/2003US6632445 Unit dosage forms for the treatment of herpes simplex
10/14/2003US6632443 Water-soluble compositions of bioactive lipophilic compounds
10/14/2003US6632440 Chronic obstructive pulmonary disease (COPD), asthma; Aerosol administration a compound that inhibits exocytosis in mucus secreting cells produced by modifying a clostridial neurotoxin
10/14/2003US6632428 Hyperlipidemia, lowering both the serum cholesterol and serum triglyceride levels, culturing a Lovastatin-producing Monascus strain
10/14/2003US6632423 To prevent or reduce fibrosis and/or adhesion in traumatized tissues, comprising the administration of a stabilizing effective amount of the agent to the traumatized tissue
10/14/2003US6632419 Increasing libido in humans via acute testosterone administration
10/14/2003US6632389 Underwater or under-hydrocarbon pelletizing of biologically-active-compound-containing melts
10/14/2003US6632217 Implantable osmotic pump
10/14/2003US6632216 Ingestible device
10/14/2003US6632215 Medical devices using electrosensitive gels
10/14/2003US6632176 Products and methods for brachytherapy
10/14/2003US6631852 Vapor dispensing device
10/14/2003CA2340221C Injectable formulations of nanoparticulate naproxen
10/14/2003CA2317019C Magnetically responsive composition
10/14/2003CA2271865C Tablet composition
10/14/2003CA2225601C New stable pharmaceutical preparation for producing propellant-free aerosols
10/14/2003CA2166465C Method of controlling the size of liposomes
10/14/2003CA2118517C Surface modified nsaid nanoparticles
10/14/2003CA2098242C Surface modified anticancer nanoparticles
10/14/2003CA2082740C Controlled release device
10/09/2003WO2003083443A2 Lipid mediated screening of drug candidates for identification of active compounds
10/09/2003WO2003082960A1 Method of producing a gel
10/09/2003WO2003082915A2 Xcrf polynucleotides and polypeptides and uses thereof
10/09/2003WO2003082882A1 Phospholipid derivative
10/09/2003WO2003082845A1 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
10/09/2003WO2003082806A1 Venlafaxine base
10/09/2003WO2003082805A1 Low water-soluble venlafaxine salts
10/09/2003WO2003082804A1 Venlafaxine besylate
10/09/2003WO2003082798A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
10/09/2003WO2003082372A2 Chemiluminescent treatment of acne
10/09/2003WO2003082370A2 Transcellular drug delivery system
10/09/2003WO2003082360A1 Drug delivery particle
10/09/2003WO2003082359A1 Tissue treatment
10/09/2003WO2003082348A1 Nanogel networks including polyion polymer fragments and biological agent compositions thereof
10/09/2003WO2003082345A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
10/09/2003WO2003082344A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
10/09/2003WO2003082343A1 Drugs for treating liver diseases with the use of hollow protein nanoparticles
10/09/2003WO2003082340A1 Injectable veterinary composition for small animals
10/09/2003WO2003082331A1 Decoy compositions for treating and preventing brain diseases and disorders
10/09/2003WO2003082330A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
10/09/2003WO2003082316A1 Microgel particles for the delivery of bioactive materials
10/09/2003WO2003082313A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003WO2003082303A1 Polymeric micelle formulations of hydrophobic compounds and methods
10/09/2003WO2003082302A2 Bioadhesive directed somatic cell therapy
10/09/2003WO2003082297A1 Meloxicam suppositories containing e.g. polyethylenglycol
10/09/2003WO2003082287A1 Dpc 333 formulation having unique biopharmaceutical characteristics
10/09/2003WO2003082285A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/09/2003WO2003082279A1 Solid preparation containing single crystal form
10/09/2003WO2003082273A1 Solubilization of weak bases
10/09/2003WO2003082262A2 Compositions of venlafaxine base
10/09/2003WO2003082261A1 Extended release venlafaxine formulations
10/09/2003WO2003082253A1 A method for treating carrier particles and its use
10/09/2003WO2003082252A1 Hfa-suspension formulations containing an anticholinergic
10/09/2003WO2003082251A2 THE EFFERVESCENT PHARMACEUTICAL DOSAGE FORM OF ESTERS AND ESTER SALTS OF 6 α METHYLPREDNISOLONE SUCCINATE, PROCEDURE FOR ITS OBTAINING AND APPLICATION
10/09/2003WO2003082250A1 Processes for manufacturing polymeric microspheres
10/09/2003WO2003082249A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003WO2003082248A2 Taste masked compositions of erythromycin a and derivatives thereof
10/09/2003WO2003082247A2 Drug microparticles
10/09/2003WO2003082246A1 Stabilized natural cannabinoid formulation
10/09/2003WO2003082245A1 Methods of using lamellar bodies for therapeutic purposes
10/09/2003WO2003082244A2 Hfa-suspension formulation of an anhydrate
10/09/2003WO2003082243A1 Oral suspension formulation
10/09/2003WO2003082242A2 Highly aqueous liquid carrier formulations
10/09/2003WO2003082241A2 Clarithromycin formulations having improved bioavailability
10/09/2003WO2003082240A1 Preparation containing fatty acid, used for reducing appetite, satiating, and/or reducing weight
10/09/2003WO2003082220A2 Method for producing emulsions
10/09/2003WO2003082213A2 Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
10/09/2003WO2003082209A2 Cochleates made with purified soy phosphatidylserine
10/09/2003WO2003082207A2 Volume efficient controlled release dosage form
10/09/2003WO2003082204A2 Sustained-release gel coated compositions
10/09/2003WO2003082193A2 Suramin and derivatives thereof as topical microbicide and contraceptive
10/09/2003WO2003082164A1 Sheet-type patch
1 ... 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 ... 2991